Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.40 -0.02 (-5.09%)
As of: Oct 21, 2026 · 3:59 PM EDT

Citius Pharmaceuticals (CTXR) Total Current Liabilities (2011 - 2026)

Updated

Citius Pharmaceuticals' Total Current Liabilities came in at $51.65 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 0.4% from $51.84 million a year earlier and down 6.1% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals' Total Current Liabilities was $44.91 million, up 25.4% from FY2024.

  • Total Current Liabilities has increased in each of the last four fiscal years, with a five-year compound annual growth rate of 61.4% (FY2020 to FY2025).
  • Going back by fiscal year, Total Current Liabilities was $35.81 million in FY2024 (+519.7%), $5.78 million in FY2023 (+27.6%), $4.53 million in FY2022 (+13.8%) and $3.98 million in FY2021 (-2.8%).
  • The five-year range for quarterly Total Current Liabilities is $3.98 million (fiscal Q4 2021) to $55.02 million (fiscal Q2 2026).
  • Year-over-year, Total Current Liabilities increased in four of the last six quarters, with growth averaging 207.2%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in fiscal Q1 2025 (growth of 703.1%), and the weakest in fiscal Q1 2023 (a decline of 38.2%).
  • Business Quant data shows CTXR's Total Current Liabilities at $55.02 million (Q2 2026), $38.21 million (Q1 2026) and $44.91 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Citius Pharmaceuticals 10.37 Mn -23.20 Mn 1.00 Mn 51.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.65 Mn
Mar 31, 2026 55.02 Mn
Dec 31, 2025 38.21 Mn
Sep 30, 2025 44.91 Mn
Jun 30, 2025 51.84 Mn
Mar 31, 2025 49.88 Mn
Dec 31, 2024 44.81 Mn
Sep 30, 2024 35.81 Mn
Jun 30, 2024 4.15 Mn
Mar 31, 2024 4.17 Mn
Dec 31, 2023 5.58 Mn
Sep 30, 2023 5.78 Mn
Jun 30, 2023 5.79 Mn
Mar 31, 2023 6.21 Mn
Dec 31, 2022 4.54 Mn
Sep 30, 2022 4.53 Mn
Jun 30, 2022 4.46 Mn
Mar 31, 2022 4.02 Mn
Dec 31, 2021 7.34 Mn
Sep 30, 2021 3.98 Mn
API Access

Citius Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CTXR&period=max&api_key=YOUR_API_KEY